What You Should Know: – Boston Scientific announces an agreement to acquire Preventice Solutions, a leading developer of mobile health solutions and remote monitoring services that connect patients and caregivers for $925M in cash. – The acquisition of external cardiac monitoring technologies and services providers… Read More »Boston Scientific Acquires Preventice Solutions for $925M in Cash
When evaluating a new diagnostic, HTA agencies must assess two separate issues: analytical and clinical validity. Analytical validity basically indicates whether the test works; is it able to accurately predicts the presence or absence of a particular biomarker of interest. Clinical validity is whether the… Read More »HTA criteria used to evaluate diagnostics
When evaluating a new diagnostic, HTA agencies must assess two separate issues: analytical and clinical validity. Analytical validity basically indicates whether the test works; is it able to accurately predicts the presence or absence of a particular biomarker of interest. Clinical validity is whether the… Read More »HTA criteria used to evaluate diagnostics
What You Should Know: – Today, Talis Biomedical Corporation announced it has been awarded a $25M contract from the National Institutes of Health (NIH) as part of Phase 2 of its Rapid Acceleration of Diagnostics (RADx) initiative as well as another $100 million in additional… Read More »Talis Awarded $25M NIH Contract for Point-of-Care COVID-19 Testing